- Home
- OUT vs JANX Comparison
OUT vs JANX Comparison
Compare OUT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- JANX
- Stock Information
- Founded
- OUT 2013
- JANX 2017
- Country
- OUT United States
- JANX United States
- Employees
- OUT N/A
- JANX N/A
- Industry
- OUT Real Estate Investment Trusts
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- OUT Real Estate
- JANX Health Care
- Exchange
- OUT Nasdaq
- JANX Nasdaq
- Market Cap
- OUT 3.0B
- JANX 2.9B
- IPO Year
- OUT N/A
- JANX 2021
- Fundamental
- Price
- OUT $17.91
- JANX $48.52
- Analyst Decision
- OUT Hold
- JANX Strong Buy
- Analyst Count
- OUT 5
- JANX 10
- Target Price
- OUT $19.25
- JANX $65.10
- AVG Volume (30 Days)
- OUT 2.0M
- JANX 675.5K
- Earning Date
- OUT 11-12-2024
- JANX 11-06-2024
- Dividend Yield
- OUT 9.22%
- JANX N/A
- EPS Growth
- OUT N/A
- JANX N/A
- EPS
- OUT 1.38
- JANX N/A
- Revenue
- OUT $1,838,900,000.00
- JANX $13,049,000.00
- Revenue This Year
- OUT N/A
- JANX $66.30
- Revenue Next Year
- OUT $2.31
- JANX N/A
- P/E Ratio
- OUT $12.99
- JANX N/A
- Revenue Growth
- OUT 1.37
- JANX 54.12
- 52 Week Low
- OUT $11.98
- JANX $7.79
- 52 Week High
- OUT $19.33
- JANX $65.60
- Technical
- Relative Strength Index (RSI)
- OUT 45.58
- JANX 39.32
- Support Level
- OUT $16.94
- JANX $50.51
- Resistance Level
- OUT $19.12
- JANX $57.48
- Average True Range (ATR)
- OUT 0.59
- JANX 2.86
- MACD
- OUT -0.01
- JANX -0.81
- Stochastic Oscillator
- OUT 44.50
- JANX 0.66
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's major customers include entities within the retail, television, healthcare, and entertainment industries.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.